Announcing the winners of the AMGEN Golden Ticket
Delve Therapeutics and Mitokinin have won the Amgen Golden Ticket at MBC BioLabs. Each company receives one year of lab bench space and more.
UCSF Biomaterials and Bioengineering Correlative Microscopy Core Showcase: Correlative Imaging
June 7, 2018 Correlative microscopy is a sophisticated approach that combines the imaging capabilities of typically separate, but powerful microscopy platforms. Misun Kang, PhD UCSF Micro-CT Dr. Kang [...]
Australia for Early Phase Clinical Development
May 16, 2018 Novotech and CoSec will be onsite to discuss the advantageous Australian regulatory landscape for early phase clinical development. Fast regulatory timelines and the 43.5% research and d [...]
Reimaging Clinical Trials and Drug Development
May 15, 2018 As a biotech company matures, clinical trials will take up a disproportionate amount of resources for a clinical stage company. The CEO of Trialspark, Benjamine Liu, will give an overvie [...]
Nitto Partners with MBC BioLabs for a New Startup Incubator
Nitto will serve as the Founding Partner for MBC BioLabs’ new co-working laboratory facility in San Carlos.
AMGEN and MBC BioLabs invite you to apply for the 2018 AMGEN Golden Ticket!
Looking for a free year of lab space at San Francisco's premier life sciences incubator? Amgen can help! Amgen is awarding up to 2 Golden Tickets to high-potential and innovative life science and biot [...]
Corning Sponsorship in San Carlos
Corning is pleased to announce sponsorship of the new MBC BioLabs site at San Carlos with the placement of several brand new instruments! Corning is a trusted supplier to the healthcare and pharmaceut [...]
Indee Labs Secures Funding to Develop Unique Gene Therapy Manufacturing Technology in Australia
Read Full Press Release Indee Labs will receive grant funding of nearly $1M from the Australian Government’s $35 million BioMedTech Horizons program. The project will see Indee Labs make a new genera [...]
